Holen Sie sich die Stockscreener-App
5.175
0.19%
-0.025
Schlusskurs vom Vortag:
$5.20
Offen:
$5.2
24-Stunden-Volumen:
369.99K
Relative Volume:
0.20
Marktkapitalisierung:
$496.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-144.32M
KGV:
-2.3739
EPS:
-2.18
Netto-Cashflow:
$-105.21M
1W Leistung:
-0.29%
1M Leistung:
-20.15%
6M Leistung:
+19.59%
1J Leistung:
+16.63%
1-Tages-Spanne:
$5.13
$5.35
1-Wochen-Bereich:
$5.09
$5.65
52-Wochen-Spanne:
$2.25
$7.085
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Firmenname
Compass Pathways Plc Adr
Sektor
Branche
Telefon
1-716-676-6461
Adresse
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Vergleichen Sie CMPS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
5.175 | 499.29M | 0 | -144.32M | -105.21M | -2.18 |
|
HCA
Hca Healthcare Inc
|
486.90 | 108.68B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
190.95 | 16.41B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.20 | 13.10B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
232.07 | 14.08B | 16.08B | 1.20B | 1.06B | 17.82 |
|
EHC
Encompass Health Corp
|
114.25 | 11.35B | 5.51B | 494.70M | 386.40M | 4.84 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-02-27 | Eingeleitet | Stifel | Buy |
| 2024-07-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2022-11-21 | Fortgesetzt | Berenberg | Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-10-29 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
| 2021-05-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-01 | Eingeleitet | ROTH Capital | Buy |
| 2020-10-14 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-13 | Eingeleitet | Berenberg | Buy |
| 2020-10-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-10-13 | Eingeleitet | Cowen | Outperform |
| 2020-10-13 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Compass Pathways Plc Adr Aktie (CMPS) Neueste Nachrichten
Investors in cash trouble should check out Compass Pathways Plc ADR (CMPS) - Setenews
Bridger Management LLC Purchases New Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
The time has not yet come to remove your chips from the table: Compass Pathways Plc ADR (CMPS) - Setenews
Free cash flow per share of COMPASS Pathways Plc Sponsored ADR – LS:A2QCDR - TradingView
COMPASS Pathways (NASDAQ:CMPS) Shares Gap UpTime to Buy? - MarketBeat
This trade activity should not be overlooked: Compass Pathways Plc ADR (CMPS) - Setenews
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months - Placera.se
Sumitomo Mitsui Trust Group Inc. Has $615,000 Stock Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression - Barchart.com
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors - ANSA
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 - Barchart.com
ARK Investment Management LLC Sells 155,582 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Compass Pathways soars 62% after December Fair Value signal - Investing.com
Compass Pathways: Maintain Hold Rating With COMP360 Going Beyond TRD Development (CMPS) - Seeking Alpha
COMPASS Pathways (NASDAQ:CMPS) Reaches New 52-Week High After Analyst Upgrade - Defense World
COMPASS Pathways (NASDAQ:CMPS) Price Target Raised to $14.00 at BTIG Research - Defense World
COMPASS Pathways (NASDAQ:CMPS) Sets New 52-Week High After Analyst Upgrade - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Sets New 12-Month HighWhat's Next? - MarketBeat
Goldman Sachs Group Inc. Sells 81,540 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading 6.4% HigherShould You Buy? - MarketBeat
Brokerages Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) PT at $16.29 - MarketBeat
Woodline Partners LP Purchases 1,292,927 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Polar Asset Management Partners Inc. Acquires Shares of 229,806 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Vident Advisory LLC Invests $95,000 in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
Driehaus Capital Management LLC Invests $2.01 Million in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Nantahala Capital Management LLC Purchases 1,829,232 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
DAFNA Capital Management LLC Raises Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $16.29 Consensus Target Price from Analysts - Defense World
22NW LP Acquires New Position in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
CMPS Stock Price and Chart — NASDAQ:CMPS - TradingView
HC Wainwright Issues Negative Outlook for CMPS Earnings - Defense World
Analysts Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Price Target at $17.00 - Defense World
Compass (CMPS) Q2 Loss Improves 27% - The Globe and Mail
Can Compass Pathways Plc ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Compass Pathways appoints former GW Pharmaceuticals CEO to board - Investing.com India
Compass Pathways appoints former GW Pharmaceuticals CEO to board By Investing.com - Investing.com South Africa
HC Wainwright Lowers Earnings Estimates for COMPASS Pathways - Defense World
Equities Analysts Issue Forecasts for CMPS Q1 Earnings - Defense World
CMPS: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $17.00 Average Target Price from Brokerages - Defense World
WPP (LON:WPP) Stock Price Down 18.8% Following Analyst Downgrade - Defense World
Helen of Troy (NASDAQ:HELE) Hits New 1-Year Low After Earnings Miss - Defense World
Promising Chinese Stocks To Research – July 9th - Defense World
Epiroc AB (publ) (EPOKY) Projected to Post Earnings on Friday - Defense World
COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why - MSN
This Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip? - Barchart.com
Compass’ stock slips despite psilocybin trial hitting target - Clinical Trials Arena
Compass Pathways reports positive Phase 3 trial results for COMP360 in depression - Investing.com
Compass Pathways Holds Annual General Meeting By Investing.com - Investing.com South Africa
Compass Pathways Holds Annual General Meeting - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - Nasdaq
Finanzdaten der Compass Pathways Plc Adr-Aktie (CMPS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.16%
3.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):